177 LuLu-DOTATATE for Advanced Intracranial Meningioma: The MOMENTUM-1 (RTOG3523) Study Investigators’ Perspective

Key Points

• Assess the efficacy of 177Lu-DOTATATE for treating advanced intracranial meningioma.
• Involved the MOMENTUM-1 (RTOG3523) trial based on the clinical application of 177Lu-DOTATATE.
• Registry ID provided is NCT06944169, indicating interventional aspects.
• Study uses considerations from both MOMENTUM-1 and the LUMEN-1 protocols.
• Potential therapeutic benefits have been reported from previous findings.
• Expected outcomes are compared against the novel LUMEN-1 study.
• Further insights on treatment efficacy are anticipated from ongoing analyses.